DENVER, Nov. 01, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, Inc. a continuous health monitoring and clinical intelligence company, today announced the launch of its patented, FDA-cleared, pulse ...
The new Universal ReSposable pulse oximetry sensor was created after more than 10 years of research and development with feedback from hundreds of clinicians on what they wanted most in a sensor – ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果